An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...
Bacitracin/Neomycin/Polymyxin-B 400u/3.5mg/10,000u/gm Ointment Y41.8 Bacitracin/Polymyxin-B 500u/10,000u/gm Ointment Y41.8 ...
Orthogon Therapeutics, a privately held research and development (R&D) company, uses principles of biophysics and structure-based drug design to develop anti-infective small molecules that ...
Hosted on MSN1mon
Researchers source new drugs from toxic birdsBacteria are a valuable source for the discovery of natural products that can be used for the development of new drugs ... toward the development of new anti-infectives, particularly against ...
News Medical on MSN10d
Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infectionsCentauri Therapeutics Limited (Centauri), an immunotherapy company with a unique and proprietary platform technology ...
SYDNEY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic anti-infectives, today announced it was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback